The log-rank test is widely used to compare two survival distributions in a randomized clinical trial, while partial likelihood (Cox, 1975) is the method of choice for making inference about the hazard ratio under the Cox (1972) proportional hazards model. The Wald 95% confidence interval of the hazard ratio may include the null value of 1 when the p-value of the log-rank test is less than 0.05. Peto et al. (1977) provided an estimator for the hazard ratio based on the log-rank statistic; the corresponding 95% confidence interval excludes the null value of 1 if and only if the p-value of the log-rank test is less than 0.05. However, Peto’s estimator is not consistent, and the corresponding confidence interval does not have correct coverage ...
The hazard ratio (HR) has been the most popular measure to quantify the magnitude of treatment effec...
Under the assumption of proportional hazards, the log-rank test is optimal for testing the null hypo...
International audienceTo compare two or more survival distributions with interval-censored data, var...
Background: The logrank test and the Cox proportional hazards model are routinely applied in the des...
1noProportional hazards are a common assumption when designing confirmatory clinical trials in onco...
Many clinical trials include time-to-event or survival data as an outcome. To compare two survival d...
The log-rank test is a cornerstone of phase III oncology clinical trials. However, there are at leas...
Nonproportional hazards (NPH) have been observed in confirmatory clinical trials with time to event ...
The hazard ratio derived from the Cox model is a commonly used summary statistic to quantify a treat...
In confirmatory cancer clinical trials, overall survival (OS) is normally a primary endpoint in the ...
Existing methods for comparing the means of two independent skewed log-normal distributions do not p...
Background: It is not uncommon for clinical trials to present results on survival time as Kaplan-Me...
Abstract Background Numerous statistical methods can ...
This paper focuses on interval estimation in logistic regression models fitted through the Firth pe...
With censored event time observations, the logrank test is the most popular tool for testing the equ...
The hazard ratio (HR) has been the most popular measure to quantify the magnitude of treatment effec...
Under the assumption of proportional hazards, the log-rank test is optimal for testing the null hypo...
International audienceTo compare two or more survival distributions with interval-censored data, var...
Background: The logrank test and the Cox proportional hazards model are routinely applied in the des...
1noProportional hazards are a common assumption when designing confirmatory clinical trials in onco...
Many clinical trials include time-to-event or survival data as an outcome. To compare two survival d...
The log-rank test is a cornerstone of phase III oncology clinical trials. However, there are at leas...
Nonproportional hazards (NPH) have been observed in confirmatory clinical trials with time to event ...
The hazard ratio derived from the Cox model is a commonly used summary statistic to quantify a treat...
In confirmatory cancer clinical trials, overall survival (OS) is normally a primary endpoint in the ...
Existing methods for comparing the means of two independent skewed log-normal distributions do not p...
Background: It is not uncommon for clinical trials to present results on survival time as Kaplan-Me...
Abstract Background Numerous statistical methods can ...
This paper focuses on interval estimation in logistic regression models fitted through the Firth pe...
With censored event time observations, the logrank test is the most popular tool for testing the equ...
The hazard ratio (HR) has been the most popular measure to quantify the magnitude of treatment effec...
Under the assumption of proportional hazards, the log-rank test is optimal for testing the null hypo...
International audienceTo compare two or more survival distributions with interval-censored data, var...